4.5 Article

Persistence of Intact Retinal Ganglion Cell Terminals After Axonal Transport Loss in the DBA/2J Mouse Model of Glaucoma

Journal

JOURNAL OF COMPARATIVE NEUROLOGY
Volume 524, Issue 17, Pages 3503-3517

Publisher

WILEY
DOI: 10.1002/cne.24012

Keywords

synapse; retinal; bouton; superior colliculus; mitochondria; neurodegeneration; RRID:IMSR_JAX:000671; RRID:IMSR_JAX: 007048; RRID:SCR_002716; RRID:SCR_002865

Funding

  1. National Eye Institute [EY002358]
  2. National Institute on Deafness and Other Communication Disorders [DC04391]

Ask authors/readers for more resources

Axonal transport defects are an early pathology occurring within the retinofugal projection of the DBA/2J mouse model of glaucoma. Retinal ganglion cell (RGC) axons and terminals are detectable after transport is affected, yet little is known about the condition of these structures. We examined the ultrastructure of the glaucomatous superior colliculus (SC) with three-dimensional serial block-face scanning electron microscopy to determine the distribution and morphology of retinal terminals in aged mice exhibiting varying levels of axonal transport integrity. After initial axonal transport failure, retinal terminal densities did not vary compared with either transport-intact or control tissue. Although retinal terminals lacked overt signs of neurodegeneration, transportintact areas of glaucomatous SC exhibited larger retinal terminals and associated mitochondria. This likely indicates increased oxidative capacity and may be a compensatory response to the stressors that this projection is experiencing. Areas devoid of transported tracer label showed reduced mitochondrial volumes as well as decreased active zone number and surface area, suggesting that oxidative capacity and synapse strength are reduced as disease progresses but before degeneration of the synapse. Mitochondrial volume was a strong predictor of bouton size independent of pathology. These findings indicate that RGC axons retain connectivity after losing function early in the disease process, creating an important therapeutic opportunity for protection or restoration of vision in glaucoma. (C) 2016 Wiley Periodicals, Inc.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available